Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 14.47%
March 31, 2026 14.33%
December 31, 2025 14.30%
September 30, 2025 12.62%
June 30, 2025 14.09%
March 31, 2025 13.97%
December 31, 2024 13.81%
September 30, 2024 13.45%
June 30, 2024 13.72%
March 31, 2024 11.41%
December 31, 2023 12.33%
September 30, 2023 12.96%
June 30, 2023 12.50%
March 31, 2023 11.67%
December 31, 2022 12.59%
September 30, 2022 12.31%
June 30, 2022 13.03%
March 31, 2022 12.90%
December 31, 2021 12.65%
September 30, 2021 13.19%
June 30, 2021 13.68%
March 31, 2021 13.34%
December 31, 2020 11.26%
September 30, 2020 13.42%
June 30, 2020 13.01%
Date Value
March 31, 2020 15.10%
December 31, 2019 13.32%
September 30, 2019 11.28%
June 30, 2019 11.07%
March 31, 2019 12.14%
December 31, 2018 11.58%
September 30, 2018 10.48%
June 30, 2018 10.91%
March 31, 2018 11.46%
December 31, 2017 9.96%
September 30, 2017 9.50%
June 30, 2017 8.48%
March 31, 2017 9.92%
December 31, 2016 7.82%
September 30, 2016 8.14%
June 30, 2016 9.61%
March 31, 2016 10.86%
December 31, 2015 11.14%
September 30, 2015 11.04%
June 30, 2015 12.00%
March 31, 2015 12.92%
December 31, 2014 11.62%
September 30, 2014 10.83%
June 30, 2014 12.76%
March 31, 2014 15.65%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Chemed Corp. 30.37%
National HealthCare Corp. 73.30%
Regional Health Properties, Inc. 27.39%
Oncologix Tech, Inc. --
InnovAge Holding Corp. 21.46%